Patient-Specific Techniques for Hip Replacement

Sponsor
Centre de l'arthrose, Paris (Other)
Overall Status
Recruiting
CT.gov ID
NCT03975673
Collaborator
(none)
460
1
2
42
11

Study Details

Study Description

Brief Summary

Background

  • In the 19th century, Sir John Charnley successfully introduced total joint replacements for hips. In order to prevent implant fixation failure and accelerated polyethylene wear, it was initially recommended that implants were systematically positioned in a "biomechanically-friendly" way, which disregarded most of the individual anatomy (medialized acetabular cup, systematized cup version and inclination, etc.)

  • While those initial surgical techniques made popular and clinically successful total joint replacements, many complications (aseptic loosening, pain, excessive wear) have remained and mainly the persistence of frequent instability after THA. In response to those complications, many improvements were developed in the area of joint replacement over the last few decades, with one the most recent dating from 2017 and being the development of a surgical technique Rationale

  • The kinematic alignment (KA) technique for total hip arthroplasty (THA) aims at restoring the acetabular center of rotation and as much as possible the constitutional acetabular anteversion by using the transverse acetabular ligament (TAL) as a reference landmark. Also, the technique aims (1) at making personalized choice for the hip component design, (2) at defining the cup positioning, and (3) at sometimes considering additional spine surgery based on the assessment of the individual spine-hip relation.

  • KA techniques for hip replacements are relatively new, likely to become popular over time, and their true value remains to be determined.

Condition or Disease Intervention/Treatment Phase
  • Procedure: hip replacement
N/A

Detailed Description

  • Objective: Evaluation of the kinematic alignment technique for hip prostheses in patient with hip osteoarthritis

  • Hypothesis: the consideration of hip pathoanatomy and lumbo-pelvic kinematic disorder when planning a hip replacement is likely to decrease the risk of prosthetic dislocation and improve patient function and satisfaction

Study Design

Study Type:
Interventional
Anticipated Enrollment :
460 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Prospective two-arms consecutive patients studyProspective two-arms consecutive patients study
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Kinematic vs Mechanical Alignment Technique for Primary Total Hip Replacement in Patient With Hip Arthritis: a Prospective Comparative Non Randomised Study
Actual Study Start Date :
Jan 1, 2020
Anticipated Primary Completion Date :
Jul 1, 2020
Anticipated Study Completion Date :
Jul 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Conventional Total Hip Replacement (cTHR )

Osteoarthritic patient undergoing the conventional technique medializing the hip center of rotation obtain a standing acetabular cup position fitting the Lewinneck recommendations (inclination 40°±10°, version 15°±10°)

Procedure: hip replacement
Osteoarthritic patient undergoing the conventional technique or the kinematically aligned technique

Experimental: Kinematically Aligned Total Hip Replacement (KATHR )

Osteoarthritic patient undergoing the kinematically aligned technique restoring the acetabular center of rotation restoring the constitutional acetabular anteversion by using the transverse acetabular ligament (TAL) as a reference landmark. making personalized choice for the hip component design considering additional spine surgery based on the assessment of the individual spine-hip relation.

Procedure: hip replacement
Osteoarthritic patient undergoing the conventional technique or the kinematically aligned technique

Outcome Measures

Primary Outcome Measures

  1. Dislocation rate [Occurrence within the first year after primary total hip replacement]

    The rates of occurrence of hip dislocation (treated in the hospital or in an outpatient setting).

Secondary Outcome Measures

  1. EuroQualityOfLife 5 dimension index (EQ5D) [Preoperative, postoperative 6 months and 12 months . assessment for all parameters.]

    EQ5D is a generic QoL scale from -0.6 to 1

  2. Oxford hip score (OHS) [Preoperative, postoperative 6 months and 12 months . assessment for all parameters.]

    OHS is a rate of hip function from 0 to 48

  3. satisfaction visual analogic scale (VAS) [Preoperative, postoperative 6 months and 12 months . assessment for all parameters.]

    satisfaction is a VAS score from 0 to 100

  4. Implant positioning parameter [Preoperative, postoperative 6 months and 12 months . assessment for all parameters.]

    Implant positioning parameters (inclination, version, offset) are computed on post-operative X rays acquisition.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Osteoarthritic hip patients eligible for primary total hip arthroplasty (THR).

  • 18 years-old with no upper age limit

  • Affiliated to a social security scheme

Exclusion Criteria:
  • Pregnant or lactating women or in age to procreate without contraceptive treatment

  • History of mental illness or neurological deficit or adults lacking capacity to consent for themselves

  • Prisoners or young offenders

  • Persons who might not adequately understand verbal explanations or written information given in French, or who have special communication needs

  • Subjects having been or being frequently x-ray examination

  • Heart failure with risk of exercise angina or comorbidity(ies) significantly affecting patient function

  • Any participants who are involved in current research or have recently been involved in any research prior to recruitment.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Université de Paris Paris France 75011

Sponsors and Collaborators

  • Centre de l'arthrose, Paris

Investigators

  • Principal Investigator: Cedric Maillot, centre de l'arthrose

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre de l'arthrose, Paris
ClinicalTrials.gov Identifier:
NCT03975673
Other Study ID Numbers:
  • PST-HR
First Posted:
Jun 5, 2019
Last Update Posted:
Apr 7, 2020
Last Verified:
Apr 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre de l'arthrose, Paris
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 7, 2020